If you've been researching weight-loss medication in Singapore, you've likely come across the name Wegovy. Since its approval by the Health Sciences Authority (HSA), Wegovy has become one of the most clinically discussed options for chronic weight management — not because it's new, but because the evidence behind it is unusually strong.
For a comprehensive guide to medical weight loss, see our complete guide.
Wegovy in Singapore: How to Get Prescribed, Cost & What to Expect
If you've been researching weight-loss medication in Singapore, you've likely come across the name Wegovy. Since its approval by the Health Sciences Authority (HSA), Wegovy has become one of the most clinically discussed options for chronic weight management — not because it's new, but because the evidence behind it is unusually strong.
This guide covers what Wegovy is, who qualifies, how to get a prescription in Singapore, what it costs, and what the treatment journey actually looks like.
What Is Wegovy?
Wegovy (semaglutide 2.4 mg) is a once-weekly injectable medication developed by Novo Nordisk. It belongs to a class of drugs called GLP-1 receptor agonists, which work by mimicking the glucagon-like peptide-1 hormone — a naturally occurring hormone that regulates appetite and food intake.
It is not a supplement. It is not a diet pill. Wegovy is a prescription-only medication, approved specifically for chronic weight management in adults with obesity or overweight with at least one weight-related health condition.
In the landmark STEP 1 clinical trial (published in the New England Journal of Medicine, 2021), adults treated with semaglutide 2.4 mg achieved a mean weight reduction of 14.9% over 68 weeks, compared to 2.4% in the placebo group. The STEP programme across multiple trials consistently demonstrated clinically meaningful, sustained weight loss when combined with diet and exercise changes.¹
Is Wegovy Approved in Singapore?
Yes. Wegovy (semaglutide 2.4 mg) is registered with the Health Sciences Authority (HSA) of Singapore for the treatment of chronic weight management in adults.
HSA registration confirms that the product has met Singapore's standards for quality, safety, and efficacy based on clinical data submitted through the New Drug Application (NDA) process. As a registered prescription medication, it can only be dispensed by a licensed pharmacy following a valid doctor's prescription.
Who Qualifies for Wegovy in Singapore?
Your doctor will assess eligibility based on clinical criteria similar to those used in the approved indication:
- BMI ≥ 30 kg/m² (obesity), or
- BMI ≥ 27 kg/m² with at least one weight-related comorbidity, such as:
- Type 2 diabetes or pre-diabetes
- Hypertension
- Dyslipidaemia (high cholesterol/triglycerides)
- Obstructive sleep apnoea
- Cardiovascular disease
Wegovy is not suitable for everyone. Contraindications include a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or a prior serious hypersensitivity reaction to semaglutide. Patients with pancreatitis history require careful evaluation.
A proper medical consultation is essential before starting treatment.
How to Get Wegovy Prescribed in Singapore
There is no over-the-counter route. To access Wegovy in Singapore, you need a prescription from a licensed doctor. Here's what the typical process looks like:
Step 1: Initial Consultation
You meet with a doctor — typically at a general practice clinic, specialist obesity clinic, or a telehealth platform. The doctor reviews your medical history, current BMI, weight-related health conditions, medications, and goals.
Step 2: Assessment & Blood Work
Most doctors will request baseline blood tests (HbA1c, lipid panel, thyroid function, liver enzymes) to establish your metabolic baseline and rule out contraindications.
Step 3: Prescription & Dosing Plan
If you're a suitable candidate, the doctor issues a prescription and walks you through Wegovy's dose escalation schedule:
| Week | Dose |
|---|---|
| 1–4 | 0.25 mg/week |
| 5–8 | 0.5 mg/week |
| 9–12 | 1.0 mg/week |
| 13–16 | 1.7 mg/week |
| 17+ | 2.4 mg/week (maintenance) |
The gradual escalation is designed to reduce gastrointestinal side effects (nausea, vomiting, diarrhoea), which are most common in the early weeks.
Step 4: Dispensing
The prescription is fulfilled at a licensed pharmacy. Wegovy requires cold-chain storage (2–8°C) and comes as a pre-filled auto-injector pen. Your doctor or pharmacist will demonstrate proper injection technique (typically administered subcutaneously in the abdomen, thigh, or upper arm).
Step 5: Ongoing Monitoring
Weight loss medication is not a set-and-forget treatment. Regular follow-ups (monthly in the early phase, then quarterly) allow your doctor to track your response, manage side effects, and adjust the plan if needed.
Wegovy Cost in Singapore
Wegovy is not subsidised under Medisave or the national formulary for weight management in Singapore, meaning cost is typically borne out-of-pocket.
Approximate costs (private, out-of-pocket):
| Item | Estimated Cost (SGD) |
|---|---|
| Initial consultation | $80–$200 |
| Blood tests (baseline) | $100–$250 |
| Wegovy monthly supply (2.4 mg) | $500–$800+ |
| Follow-up consultations | $60–$150 per visit |
Prices are indicative and vary by clinic and pharmacy. Confirm current pricing directly with your provider.
It's also worth noting that most patients require treatment for at least 12 months to achieve and sustain meaningful weight loss. The total first-year cost, including consultations and medication, typically ranges from SGD $7,000–$12,000+.
This is a significant commitment. It's worth discussing honestly with your doctor whether the cost-benefit ratio makes sense for your situation.
What to Expect: The Treatment Journey
Weeks 1–4: Most patients report mild nausea, especially around injection time. Appetite begins to decrease. Weight change is modest at this early stage.
Weeks 4–12: Nausea typically subsides as your body adjusts. Appetite suppression becomes more noticeable. Many patients begin to see consistent, measurable weight loss.
Weeks 12–68 (maintenance at 2.4 mg): The majority of weight loss occurs during this phase. Clinically, the STEP 1 trial showed peak weight loss around weeks 60–68.
After stopping: This is a critical point that many guides gloss over. Weight loss achieved with semaglutide is not necessarily permanent once treatment ends. The STEP 4 extension study found that participants who discontinued semaglutide regained approximately two-thirds of their lost weight within one year.² This is not a failure of the drug — it reflects the chronic nature of obesity as a condition. Your doctor should discuss a long-term plan with you before you start.
Common Side Effects
The most frequently reported side effects are gastrointestinal:
- Nausea (very common, especially at initiation)
- Vomiting
- Diarrhoea or constipation
- Abdominal discomfort
Most GI side effects reduce over time. Serious but rare adverse events include pancreatitis, gallbladder disease (cholelithiasis), and potential thyroid C-cell effects (based on animal data; thyroid cancer risk in humans has not been established in clinical trials to date).
Frequently Asked Questions
Q: Can I get Wegovy through telehealth in Singapore? A: Yes, some licensed telemedicine providers in Singapore can prescribe Wegovy following a proper consultation and medical history review. The prescription must still be dispensed by a licensed pharmacy.
Q: How long does it take to see results? A: Most patients begin to notice meaningful appetite changes within 4–8 weeks. Visible weight loss typically becomes evident by weeks 8–12. Significant results are generally measured at the 6-month and 12-month marks.
Q: Is Wegovy the same as Ozempic? A: Both contain semaglutide, but they are different products. Ozempic (semaglutide 1.0 mg) is approved for Type 2 diabetes management. Wegovy (semaglutide 2.4 mg) is the higher-dose formulation approved specifically for weight management. They are not interchangeable.
Q: What's the difference between Wegovy and other weight-loss injections? A: Wegovy is the only GLP-1 receptor agonist with a 2.4 mg semaglutide dose specifically approved for weight management in Singapore. Other injectable options exist, but clinical trial data for weight loss at this magnitude is specific to the STEP trial programme for Wegovy.
Q: Can I use Medisave for Wegovy? A: Currently, Medisave cannot be used for Wegovy as a weight management treatment. Check with your clinic, as this policy may evolve.
Considering Your Options?
Noah offers medically supervised weight management programmes with licensed doctors — no guesswork, no generic plans. Consultations are conducted online for your convenience.
→ Learn more at ofnoah.sg
References:
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." N Engl J Med. 2021;384:989–1002. doi:10.1056/NEJMoa2032183
- Rubino DM, et al. "Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity." JAMA. 2021;325(14):1414–1425. doi:10.1001/jama.2021.3224
This article is for informational purposes only and does not constitute medical advice. Consult a licensed doctor before starting any prescription medication.
Find out what your BMI indicates
Your BMI indicates that you may be
()
Your estimated weight loss in 1 year*
- kg-9% · kg to kg
BMI provides an estimate of weight classification. For a thorough analysis of your weight and medical options, arrange a teleconsult with a Noah doctor.
*Medical treatment may not be appropriate for you even if you have a high BMI
*In a 72-week clinical trial of 2,539 adults with obesity or overweight (without diabetes), participants taking the highest dose of GLP-1 + GIP alongside diet and exercise.
Reading about it is a good start.
Talking to a doctor is better. Answer a few questions online and a licensed Noah doctor will take it from there, privately.
Get started
Written by our Editorial Team
Last updated 20 Apr 2026
